CureVac NVNASDAQ:CVAC
No Matches were found for
- LAST PRICE3.5400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.5300/ 1
- Ask / Lots3.5800/ 1
- Open / Previous Close0.0000 / 3.5400
- Day Range---
- 52 Week Range
- Volume100
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Select an index
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CVAC |
|---|---|---|
| 09:32 ET | 24774 | 3.46 |
| 09:34 ET | 4431 | 3.465 |
| 09:36 ET | 1929 | 3.46 |
| 09:38 ET | 752 | 3.44 |
| 09:39 ET | 100 | 3.41 |
| 09:41 ET | 227 | 3.4399 |
| 09:43 ET | 3708 | 3.47 |
| 09:45 ET | 150 | 3.45 |
| 09:48 ET | 601 | 3.43 |
| 09:56 ET | 7135 | 3.44 |
| 09:57 ET | 600 | 3.44 |
| 10:01 ET | 4700 | 3.48 |
| 10:03 ET | 17115 | 3.505 |
| 10:06 ET | 3325 | 3.525 |
| 10:08 ET | 1816 | 3.51 |
| 10:10 ET | 3143 | 3.515 |
| 10:12 ET | 3371 | 3.52 |
| 10:14 ET | 3295 | 3.53 |
| 10:15 ET | 400 | 3.5299 |
| 10:17 ET | 14647 | 3.53 |
| 10:19 ET | 151 | 3.5288 |
| 10:21 ET | 1800 | 3.54 |
| 10:24 ET | 3825 | 3.55 |
| 10:26 ET | 100 | 3.55 |
| 10:28 ET | 100 | 3.545 |
| 10:30 ET | 5033 | 3.53 |
| 10:32 ET | 400 | 3.54 |
| 10:35 ET | 4700 | 3.54 |
| 10:37 ET | 3606 | 3.545 |
| 10:39 ET | 11732 | 3.55 |
| 10:42 ET | 600 | 3.55 |
| 10:44 ET | 400 | 3.545 |
| 10:46 ET | 4679 | 3.575 |
| 10:48 ET | 2128 | 3.57 |
| 10:50 ET | 1125 | 3.5799 |
| 10:51 ET | 10600 | 3.585 |
| 10:53 ET | 1275 | 3.565 |
| 10:55 ET | 1005 | 3.555 |
| 10:57 ET | 2900 | 3.56 |
| 11:00 ET | 17448 | 3.54 |
| 11:02 ET | 800 | 3.555 |
| 11:04 ET | 400 | 3.5595 |
| 11:06 ET | 1038 | 3.575 |
| 11:08 ET | 455 | 3.5712 |
| 11:09 ET | 1656 | 3.5701 |
| 11:11 ET | 487 | 3.58 |
| 11:13 ET | 200 | 3.58 |
| 11:15 ET | 700 | 3.57 |
| 11:20 ET | 580 | 3.56 |
| 11:22 ET | 900 | 3.565 |
| 11:24 ET | 3185 | 3.5812 |
| 11:26 ET | 2904 | 3.61 |
| 11:27 ET | 1419 | 3.5996 |
| 11:29 ET | 1623 | 3.595 |
| 11:31 ET | 845 | 3.6 |
| 11:33 ET | 700 | 3.59 |
| 11:36 ET | 600 | 3.59 |
| 11:38 ET | 100 | 3.59 |
| 11:40 ET | 700 | 3.6 |
| 11:42 ET | 200 | 3.6 |
| 11:44 ET | 200 | 3.6 |
| 11:45 ET | 968 | 3.61 |
| 11:47 ET | 1500 | 3.61 |
| 11:49 ET | 700 | 3.595 |
| 11:51 ET | 1000 | 3.59 |
| 11:54 ET | 791 | 3.6 |
| 11:56 ET | 700 | 3.61 |
| 11:58 ET | 260 | 3.61 |
| 12:00 ET | 810 | 3.615 |
| 12:02 ET | 2780 | 3.6173 |
| 12:03 ET | 2491 | 3.62 |
| 12:05 ET | 868 | 3.634 |
| 12:07 ET | 370 | 3.64 |
| 12:09 ET | 39299 | 3.6 |
| 12:12 ET | 2582 | 3.605 |
| 12:14 ET | 1509 | 3.61 |
| 12:16 ET | 400 | 3.605 |
| 12:18 ET | 1882 | 3.59 |
| 12:20 ET | 926 | 3.585 |
| 12:21 ET | 1250 | 3.595 |
| 12:23 ET | 1500 | 3.575 |
| 12:25 ET | 5114 | 3.59 |
| 12:27 ET | 100 | 3.595 |
| 12:30 ET | 228 | 3.5988 |
| 12:32 ET | 539 | 3.61 |
| 12:34 ET | 1859 | 3.5975 |
| 12:38 ET | 1626 | 3.6 |
| 12:39 ET | 1453 | 3.5912 |
| 12:43 ET | 941 | 3.6 |
| 12:45 ET | 305 | 3.6 |
| 12:48 ET | 689 | 3.6 |
| 12:50 ET | 200 | 3.595 |
| 12:52 ET | 300 | 3.61 |
| 12:54 ET | 876 | 3.615 |
| 12:56 ET | 450 | 3.62 |
| 12:57 ET | 703 | 3.62 |
| 12:59 ET | 965 | 3.615 |
| 01:01 ET | 100 | 3.61 |
| 01:03 ET | 300 | 3.61 |
| 01:06 ET | 300 | 3.61 |
| 01:08 ET | 100 | 3.61 |
| 01:10 ET | 200 | 3.61 |
| 01:12 ET | 200 | 3.6 |
| 01:14 ET | 100 | 3.605 |
| 01:15 ET | 1999 | 3.6 |
| 01:19 ET | 991 | 3.5988 |
| 01:24 ET | 8129 | 3.59 |
| 01:26 ET | 7441 | 3.5812 |
| 01:28 ET | 500 | 3.6 |
| 01:32 ET | 150 | 3.5999 |
| 01:33 ET | 325 | 3.5908 |
| 01:39 ET | 200 | 3.6 |
| 01:42 ET | 100 | 3.59 |
| 01:44 ET | 2900 | 3.57 |
| 01:46 ET | 629 | 3.57 |
| 01:48 ET | 100 | 3.565 |
| 01:50 ET | 8604 | 3.59 |
| 01:53 ET | 600 | 3.585 |
| 02:02 ET | 1541 | 3.585 |
| 02:04 ET | 1131 | 3.585 |
| 02:06 ET | 3419 | 3.605 |
| 02:08 ET | 483 | 3.6088 |
| 02:09 ET | 100 | 3.61 |
| 02:11 ET | 1516 | 3.62 |
| 02:15 ET | 2404 | 3.64 |
| 02:18 ET | 6209 | 3.655 |
| 02:20 ET | 7260 | 3.66 |
| 02:22 ET | 11644 | 3.645 |
| 02:24 ET | 4690 | 3.65 |
| 02:26 ET | 3029 | 3.665 |
| 02:27 ET | 741 | 3.67 |
| 02:29 ET | 13322 | 3.675 |
| 02:31 ET | 2170 | 3.67 |
| 02:33 ET | 326 | 3.665 |
| 02:36 ET | 938 | 3.665 |
| 02:38 ET | 1619 | 3.67 |
| 02:40 ET | 3553 | 3.68 |
| 02:42 ET | 6544 | 3.68 |
| 02:44 ET | 400 | 3.68 |
| 02:45 ET | 1606 | 3.67 |
| 02:47 ET | 399 | 3.665 |
| 02:54 ET | 1026 | 3.66 |
| 02:58 ET | 8266 | 3.66 |
| 03:00 ET | 2818 | 3.64 |
| 03:02 ET | 9228 | 3.62 |
| 03:03 ET | 937 | 3.615 |
| 03:05 ET | 200 | 3.615 |
| 03:07 ET | 914 | 3.6175 |
| 03:09 ET | 600 | 3.62 |
| 03:12 ET | 400 | 3.615 |
| 03:14 ET | 911 | 3.615 |
| 03:16 ET | 2791 | 3.585 |
| 03:18 ET | 1200 | 3.58 |
| 03:20 ET | 4730 | 3.58 |
| 03:21 ET | 12723 | 3.59 |
| 03:23 ET | 1006 | 3.585 |
| 03:25 ET | 19363 | 3.585 |
| 03:27 ET | 3430 | 3.585 |
| 03:30 ET | 6152 | 3.58 |
| 03:32 ET | 69445 | 3.55 |
| 03:34 ET | 11428 | 3.52 |
| 03:36 ET | 1066 | 3.51 |
| 03:38 ET | 7310 | 3.52 |
| 03:39 ET | 9830 | 3.56 |
| 03:41 ET | 14933 | 3.59 |
| 03:43 ET | 10804 | 3.565 |
| 03:45 ET | 800 | 3.565 |
| 03:48 ET | 14788 | 3.54 |
| 03:50 ET | 10863 | 3.52 |
| 03:52 ET | 25145 | 3.535 |
| 03:54 ET | 12210 | 3.535 |
| 03:56 ET | 10354 | 3.54 |
| 03:57 ET | 6555 | 3.55 |
| 03:59 ET | 61624 | 3.54 |
Jun 24, 2024
CureVac Announces Voting Results of General Meeting, from 4:21PM ET on Monday Jun 24, 2024 by Dow Jones
4:21PM ET on Monday Jun 24, 2024 by Dow Jones
May 28, 2024
CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK, from 8:16AM ET on Tuesday May 28, 2024 by Dow Jones
8:16AM ET on Tuesday May 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CureVac NV | 794.0M | -2.7x | --- |
Abcellera Biologics Inc | 802.8M | -5.4x | --- |
Arcutis Biotherapeutics Inc | 1.1B | -3.3x | --- |
Relay Therapeutics Inc | 894.7M | -2.6x | --- |
Tango Therapeutics Inc | 989.4M | -8.4x | --- |
Urogen Pharma Ltd | 678.2M | -4.9x | --- |
Company Information
CureVac AG is a clinical-stage biopharmaceutical company, The Company strives to create transformative medicines to protect and improve people’s lives. Fueled by proprietary RNA technology platform combined with two decades of science and manufacturing, The Company is dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.
Contact Information
- Headquarters
- Friedrich-Miescher-Str. 15TUEBINGEN, Germany 72076
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of Supervisory Board
- Baron Stephenne
- Chief Executive Officer, Member of the Management Board
- Alexander Zehnder
- Chief Financial Officer, Member of the Management Board
- Pierre Kemula
- Chief Operating Officer, Member of the Management Board
- Malte Greune
- Chief Commercial Officer, Member of the Management Board
- Antony Blanc
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $794.0M |
|---|---|
Revenue (TTM) | $63.2M |
Shares Outstanding | 224.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.64 |
EPS | $-1.31 |
Book Value | $2.47 |
P/E Ratio | -2.7x |
Price/Sales (TTM) | 12.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -486.71% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
